About Novocure (NVCR)
NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell divisi... Read more
- USD11.70
- USD12.46
- USD11.70
- USD83.60
- -10.40%
- 509M
- 312.80k
- 1.84M
- 1.3B
- 10.87
- -81.20%
Stock News
27 minutes ago
Stocks Rally But Apple Hits China Hurdle; Tesla To Kick Off Magnificent Seven Reports
Yahoo
28 minutes ago
Forget Nvidia: Buy This Millionaire Maker Stock For Your Portfolio Instead
Yahoo
56 minutes ago
Airbnb's new chief business officer shares his top priorities for hosts and travelers
CNBC
58 minutes ago
Why I Sold These 3 Tech Stocks in 2024
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
